UK first to approve CRISPR treatment for diseases: what you need to know The landmark decision could transform the treatment of sickle-cell disease and β-thalassaemia — but the technology is expensive.UK first to approve CRISPR treatment for diseases: what you need to know The landmark decision could transform the treatment of sickle-cell disease and β-thalassaemia — but the technology is expensive.

https://www.nature.com/articles/d41586-023-03590-6?utm_source=Live+Audience&utm_campaign=7fe66192a7-briefing-dy-20231117&utm_medium=email&utm_term=0_b27a691814-7fe66192a7-50432164